Status:
COMPLETED
Assessment of Transnasal Humidified Rapid-insufflation Ventilatory Exchange (THRIVE) for Maternal Pre-oxygenation
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Cesarean Section Complications
Pregnancy Related
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The main objective of this study is to determine if the use of transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) can reduce by 90 seconds the time between the entry into the opera...
Eligibility Criteria
Inclusion
- major
- female
- affiliated to a social security scheme or beneficiary of such a scheme
- having voluntarily and informedly agreed to participate in the study.
- non-smoker
- free from pulmonary, cardiac and neurological pathologies
- have a normal functional respiratory test at baseline.
Exclusion
- refusal to participate in the study
- non-French speaking volunteer
- obesity defined by a body mass index greater than 30 kilogram/meter² (kg/m²)
- current pregnancy
- Volunteer in period of exclusion from further research
- Person under guardianship, curatorship or any other administrative or judicial measure of deprivation of rights and liberty
Key Trial Info
Start Date :
February 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 25 2024
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04814628
Start Date
February 15 2024
End Date
June 25 2024
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Femme Mère Enfant
Bron, France, 69500